FDA approves first medication for obstructive sleep apnea, which also promotes weight loss
Fox News
The FDA approved a new drug treatment for obstructive sleep apnea that improves the condition through weight loss. Sleep expert Dr. Wendy Troxel discusses the impact of the new development.
The drug is to be paired with a reduced-calorie diet and increased physical activity, the FDA noted. About 30 million people suffer from sleep apnea in the U.S. "Zepbound promotes weight loss and has been shown to reduce apnea events." "We still need to emphasize shifting the diet and health habits of many, but this is a fantastic start." Angelica Stabile is a lifestyle reporter for Fox News Digital.
Sally Seymour, M.D., director of the Division of Pulmonology, Allergy and Critical Care in the FDA’s Center for Drug Evaluation and Research in Washington, D.C., applauded the approval in an announcement.
American Culture Quiz: Test yourself on groundbreaking gadgets, medical marvels and Southern staples
The American Culture Quiz is a weekly test of our unique national traits, trends, history and people. This time, test your knowledge of groundbreaking gadgets, medical marvels and more.